Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iradimed (IRMD) Return on Equity (2016 - 2025)

Iradimed (IRMD) has disclosed Return on Equity for 12 consecutive years, with 0.21% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Equity fell 2.0% to 0.21% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.21%, a 2.0% decrease, with the full-year FY2024 number at 0.23%, changed 0.0% from a year prior.
  • Return on Equity was 0.21% for Q3 2025 at Iradimed, down from 0.22% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.24% in Q1 2024 to a low of 0.02% in Q1 2021.
  • A 5-year average of 0.18% and a median of 0.21% in 2025 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: dropped -14bps in 2021, then grew 13bps in 2022.
  • Iradimed's Return on Equity stood at 0.13% in 2021, then skyrocketed by 35bps to 0.18% in 2022, then skyrocketed by 31bps to 0.24% in 2023, then dropped by -8bps to 0.22% in 2024, then dropped by -2bps to 0.21% in 2025.
  • Per Business Quant, the three most recent readings for IRMD's Return on Equity are 0.21% (Q3 2025), 0.22% (Q2 2025), and 0.22% (Q1 2025).